Article
Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board.
The Journal of molecular diagnostics : JMD - 1 Nov 2015
Lane Brian R, Bissonnette Jeffrey, Waldherr Tracy, Ritz-Holland Deborah, Chesla Dave, Cottingham Sandra L, Alberta Sheryl, Liu Cong, Thompson Amanda B, Graveel Carrie, MacKeigan Jeffrey P, Noyes Sabrina L, Smith Judy, Lakhani Nehal, Steensma Matthew R
Abstract excerpt
Next-generation sequencing (NGS) capabilities can affect therapeutic decisions in patients with complex, advanced, or refractory cancer. We report the feasibility of a tumor sequencing advisory board at a regional cancer center. Specimens were analyzed for approximately 2800 mutations in 50 genes. Outcomes of interest included tumor sequencing advisory board function and processes, timely discussion of results,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
